IMOZX
Price
$25.58
Change
+$0.09 (+0.35%)
Updated
Jun 2 closing price
Net Assets
590.18M
RPTIX
Price
$99.77
Change
-$0.22 (-0.22%)
Updated
Jun 2 closing price
Net Assets
23.23B
Interact to see
Advertisement

IMOZX vs RPTIX

Header iconIMOZX vs RPTIX Comparison
Open Charts IMOZX vs RPTIXBanner chart's image
IMOZX vs RPTIX Comparison Chart in %
View a ticker or compare two or three
VS
IMOZX vs. RPTIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMOZX is a Buy and RPTIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 23.2B vs. IMOZX (590M). RPTIX pays higher dividends than IMOZX: RPTIX (0.11) vs IMOZX (0.00). IMOZX was incepted earlier than RPTIX: IMOZX (13 years) vs RPTIX (11 years). IMOZX (0.87) is less costly to investors than RPTIX (0.63). IMOZX is a more actively managed with annual turnover of: 87.00 vs. RPTIX (31.50). RPTIX has a lower initial minimum investment than IMOZX: RPTIX (500000) vs IMOZX (1000000). RPTIX annual gain was more profitable for investors over the last year : 2.77 vs. IMOZX (-3.85). IMOZX return over 5 years is better than : -13.65 vs. RPTIX (-15.67).
IMOZXRPTIXIMOZX / RPTIX
Total Expense Ratio0.830.63132%
Annual Report Gross Expense Ratio0.870.63138%
Fund Existence13 years11 years-
Gain YTD7.7352.459315%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets590M23.2B3%
Annual Yield % from dividends0.000.11-
Returns for 1 year-3.852.77-139%
Returns for 3 years15.714.47351%
Returns for 5 years-13.65-15.6787%
Returns for 10 years5.4233.7316%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USAR30.701.27
+4.32%
USA Rare Earth Inc
ATNM1.220.04
+3.39%
Actinium Pharmaceuticals
HD311.520.83
+0.27%
Home Depot
HLLY2.62-0.02
-0.76%
Holley
AMLX13.29-0.78
-5.54%
Amylyx Pharmaceuticals